DGAP-News: Dr Cornelius Baur appointed as new Deputy Chairman of the Supervisory Board of CTS EVENTIM AG & Co. KGaA
2022. május 13., péntek, 14:15
Press Release Munich, 13 May 2022. Dr Cornelius Baur has been appointed as the new Deputy Chairman of the Supervisory Board of CTS EVENTIM AG & Co. KGaA. He succeeds Professor Jobst Plog, who decided not stand for re-election after 16 years in office. The Annual Shareholders’ Meeting of the Company confirmed the appointment of Dr Baur by a large majority on 12 May 2022. Dr Cornelius Baur commented: “As coronavirus restrictions are being lifted, people are excited to be able to enjoy more cultural activities and live events again. And so am I! The fact that I am able to play a part at CTS EVENTIM AG & Co. KGaA in making this happen fills me with gratitude and pride. I look forward to being part of a constructive Supervisory Board that collaborates closely with Klaus-Peter Schulenberg, Andreas Grandinger and Alexander Ruoff on the Board of Management.” Dr Baur studied business administration at the Ludwig Maximilian University of Munich, followed by a doctorate degree focusing on the subject of strategic decision-making in the automotive industry. From 2014 to 2021, Baur headed up the German office of McKinsey as a Managing Partner, which also included organisational responsibility for the Austrian office in Vienna. In 2021, he became CEO of the European Healthcare Acquisition & Growth Company (EHC), which is listed on the Euronext exchange in Amsterdam.
Head of Corporate Communications: Investor Relations:
|
Language: | English |
Company: | CTS Eventim AG & Co. KGaA |
Rablstr. 26 | |
81669 München | |
Germany | |
Phone: | 0421/ 3666-0 |
Fax: | 0421/ 3666-290 |
E-mail: | [email protected] |
Internet: | www.eventim.de |
ISIN: | DE0005470306 |
WKN: | 547030 |
Indices: | MDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1352333 |
End of News | DGAP News Service |
1352333 13.05.2022
Közzétételek - archívum
-
» Laxxon Medical to Participate in the BIO CEO & Investor Conference
[2023.02.02. 20:15]
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]